Severe acute autoimmune hepatitis after natalizumab treatment

Digestive and Liver Disease

Volumn 44, Issue 4, 2012, Pages 356-357

  Lisotti, Andrea ^a,b   Azzaroli, Francesco ^a,b   Brillanti, Stefano ^a,b   Mazzella, Giuseppe ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; AZATHIOPRINE; BETA INTERFERON; CORTICOSTEROID; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; NATALIZUMAB;

ACUTE LIVER FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY SCREENING; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; AUTOIMMUNE HEPATITIS; BRAIN DISEASE; CASE REPORT; CORTICOSTEROID THERAPY; DETERIORATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; JAUNDICE; LETTER; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSE; REMISSION; SEVERE ACUTE AUTOIMMUNE HEPATITIS; SIDE EFFECT; STEROID THERAPY; SYSTEMIC THERAPY;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; DRUG-INDUCED LIVER INJURY; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOLOGIC FACTORS; MULTIPLE SCLEROSIS;

EID: 84857658426     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.11.003     Document Type: Letter

References (5)

1. Grieco A., Montalto M., Vero V., et al. Severe acute hepatitis resumption of interferon-Beta therapy for multiple sclerosis: a word of caution. Am J Gastroenterol 2007, 102:2606-2607.
2. Von Kalckreuth V., Lohse A.W., Schramm C. Unmasking autoimmune hepatitis under immunomodulatory treatment of multiple sclerosis-not only beta interferon. Am J Gastroenterol 2008, 103:2147-2148.
3. Bezabeh S., Flowers C.M., Kortepeter C., et al. Clinically significant liver injury in patients treated with natalizumab. Aliment Pharmacol Ther 2010, 31:1028-1035.
4. Bjornsson E., Davidsdottir L. The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice. J Hepatol 2009, 50:511-517.
5. Mancini S., Amarotti E., Vecchio S., et al. Infliximab-related hepatitis: discussion of a case and review of the literature. Intern Emerg Med 2010, 5:193-200.